Week in Review: June 9–13

Ancient apoptotic pathway connects humans to coral; lab-grown, light-sensing retinal tissue; tracking cancer with synthetic phospholipids; diving deep into the lung microbiome

Written byTracy Vence
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

FLICKR, PAUL ASMAN AND JILL LENOBLEProteome data for the coral Acropora digitifera suggest that the species have more TNF receptor-ligand superfamily (TNFSF) members—central mediators of the death receptor pathway—than “any organism described thus far, including humans,” a team led by investigators at San Diego State University (SDSU) wrote in PNAS this week (June 9). When the researchers exposed corals to a human TNFSF called HuTNFα, the protein caused apoptotic blebbing and cell death, inducing bleaching. Similarly, the researchers found, exposure of immortalized human T cells to a coral TNFSF member, AdTNF1, resulted in more cell death. The SDSU-led team concluded that coral and humans have likely shared this TNF-induced apoptotic response pathway for more than 500 million years.

“Corals are actually much more similar to humans than we ever thought,” Steven Quistad, lead author on the study, told The Scientist.

X. ZHONG. C. GUTIERREZ AND M.V. CANTO-SOLERIn a significant step toward regenerating functional retinal tissue for therapeutic applications, scientists from Johns Hopkins University have grown in culture retinal tissue, complete with functional photoreceptor cells, from human induced pluripotent stem cells (iPSCs). Their work was published in Nature Communications this week (June 10).

“The major advance here is the ability to make retinal cells that can respond to light and that form into what appears to be remarkably proper orientation,” said Bruce Conklin, a senior investigator with the Gladstone Institute of Cardiovascular Disease at the University of California, San Francisco, who was not involved with the study.

“This is a beautifully performed set of experiments to show that human iPSCs are capable of forming retinal cells that follow the expected developmental ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies